Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology and Population Health

Body weight, weight change and the risk of cardiovascular disease in patients with hypertension: a primary-care cohort study

International Journal of Obesity volume 47, pages 848–854 (2023)Cite this article

Subjects

Abstract

Background/objectives

Obesity and cardiovascular disease (CVD) often co-occur. However, the effects of excessive body weight and weight change on CVD in patients with hypertension are not clearly established. We examined the associations of BMI, weight change and the risk of CVD in patients with hypertension.

Subjects/methods

Our Data were drawn from the medical records of primary-care institutions in China. A total of 24,750 patients with valid weight measurements attending primary healthcare centers were included. Body weight were grouped in BMI categories of underweight ( < 18.5 kg/m2), healthy weight (18.5–22.9 kg/m2), overweight (23.0–24.9 kg/m2) and obesity ( ≥ 25.0 kg/m2). Weight change over 12 months was divided into: gain >4%, gain 1–4%, stable (−1 to 1%), loss 1–4%, and loss ≥4%. Cox regression analyses were used to estimate hazard ratio (HR) and 95% confidence interval (95% CI) between BMI, weight change and the risk of CVD.

Results

After multivariable adjustment, patients with obesity were related to higher risks of CVD (HR = 1.48, 95% CI: 1.19–1.85). Higher risks were seen in participants with loss ≥4% and gain >4% of body weight compared to stable weight (loss ≥4%: HR = 1.33, 95% CI: 1.04–1.70; gain >4%: HR = 1.36, 95% CI: 1.04–1.77).

Conclusion

Obesity and weight change of loss ≥4% and gain >4% were related to higher risks of CVD. Close monitoring and appropriate interventions aimed at achieving an optimal weight are needed to prevent adverse cardiovascular outcomes for patients with hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Association between baseline BMI and weight change with risk of cardiovascular disease of patients with hypertension.
Fig. 3: Subgroup analyses of association between the baseline BMI and weight change categories with cardiovascular disease stratified by baseline BMI, age, and sex.

Similar content being viewed by others

Data availability

The datasets and computer code analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134:441–50.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010;55:590–8.

    Article  PubMed  Google Scholar 

  3. Qamar A, Braunwald E. Treatment of hypertension: addressing a global health problem. JAMA. 2018;320:1751–2.

    Article  PubMed  Google Scholar 

  4. Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138:10–16.

    Article  PubMed  Google Scholar 

  5. Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285–92.

    Article  CAS  PubMed  Google Scholar 

  6. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232–45.

    Article  PubMed  Google Scholar 

  7. Leggio M, Lombardi M, Caldarone E, Severi P, D’Emidio S, Armeni M, et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res. 2017;40:947–63.

    Article  PubMed  Google Scholar 

  8. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3–15.

    Article  CAS  PubMed  Google Scholar 

  9. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment–a position paper of the The Obesity Society and The American Society of Hypertension. Obesity. 2013;21:8–24.

    Article  PubMed  Google Scholar 

  10. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573–619.

    Article  PubMed  Google Scholar 

  11. Dwivedi AK, Dubey P, Cistola DP, Reddy SY. Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies. Curr Cardiol Rep. 2020;22:25.

    Article  PubMed  Google Scholar 

  12. de Simone G, Wachtell K, Palmieri V, Hille DA, Beevers G, Dahlöf B, et al. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. Circulation. 2005;111:1924–31.

    Article  PubMed  Google Scholar 

  13. Xu W, Shubina M, Goldberg SI, Turchin A. Body mass index and all-cause mortality in patients with hypertension. Obesity. 2015;23:1712–20.

    Article  PubMed  Google Scholar 

  14. Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549–58.

    Article  PubMed  Google Scholar 

  15. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.

    Article  Google Scholar 

  16. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329–37.

    Article  CAS  PubMed  Google Scholar 

  17. Lee AK, Woodward M, Wang D, Ohkuma T, Warren B, Sharrett AR, et al. The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. J Clin Endocrinol Metab. 2020;105:152–62.

    Article  PubMed  Google Scholar 

  18. Hu J, Xu H, Zhu J, Zhang J, Li J, Chen L, et al. Association between body mass index and risk of cardiovascular disease-specific mortality among adults with hypertension in Shanghai, China. Aging. 2021;13:6866–77.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3:280–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143:e984–e1010.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, et al. Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. JAMA Netw Open. 2018;1:e183788.

    Article  PubMed  PubMed Central  Google Scholar 

  22. de Simone G, Pasanisi F, Ferrara AL, Roman MJ, Lee ET, Contaldo F, et al. Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J Cardiol. 2013;168:729–33.

    Article  PubMed  Google Scholar 

  23. Kuch B, Hense HW, Gneiting B, Döring A, Muscholl M, Bröckel U, et al. Body composition and prevalence of left ventricular hypertrophy. Circulation. 2000;102:405–10.

    Article  CAS  PubMed  Google Scholar 

  24. Zhai AB, Haddad H. The impact of obesity on heart failure. Curr Opin Cardiol. 2017;32:196–202.

    Article  PubMed  Google Scholar 

  25. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942–7.

    Article  CAS  PubMed  Google Scholar 

  26. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.

    Article  CAS  PubMed  Google Scholar 

  27. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, et al. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens. 2002;20:2239–45.

    Article  CAS  PubMed  Google Scholar 

  28. Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.

    Article  PubMed  Google Scholar 

  29. Lovren F, Teoh H, Verma S. Obesity and atherosclerosis: mechanistic insights. Can J Cardiol. 2015;31:177–83.

    Article  PubMed  Google Scholar 

  30. Jayedi A, Rashidy-Pour A, Soltani S, Zargar MS, Emadi A, Shab-Bidar S. Adult weight gain and the risk of cardiovascular disease: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2020;74:1263–75.

    Article  PubMed  Google Scholar 

  31. Gentile CL, Orr JS, Davy BM, Davy KP. Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1834–8.

    Article  CAS  PubMed  Google Scholar 

  32. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 2008;57:1422–7.

    Article  CAS  PubMed  Google Scholar 

  33. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56:351–8.

    Article  CAS  PubMed  Google Scholar 

  34. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52:2097–101.

    Article  PubMed  Google Scholar 

  35. Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162:20–26.

    Article  PubMed  Google Scholar 

  36. Doehner W, Gerstein HC, Ried J, Jung H, Asbrand C, Hess S, et al. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial. Eur Heart J. 2020;41:2668–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Nam GE, Kim W, Han K, Lee CW, Kwon Y, Han B, et al. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes: A Nationwide Cohort Study. Diabetes Care. 2020;43:2234–41.

    Article  PubMed  Google Scholar 

  38. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015;34:335–40.

    Article  CAS  PubMed  Google Scholar 

  39. Makino K, Lee S, Bae S, Chiba I, Harada K, Katayama O, et al. Absolute Cardiovascular Disease Risk Assessed in Old Age Predicts Disability and Mortality: A Retrospective Cohort Study of Community-Dwelling Older Adults. J Am Heart Assoc. 2021;10:e022004.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594:2061–73.

    Article  CAS  PubMed  Google Scholar 

  41. Katsoulis M, Stavola BD, Diaz-Ordaz K, Gomes M, Lai A, Lagiou P, et al. Weight Change and the Onset of Cardiovascular Diseases: Emulating Trials Using Electronic Health Records. Epidemiology. 2021;32:744–55.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32:S8–S14.

    Article  Google Scholar 

Download references

Acknowledgements

We sincerely thank all the general practitioners who kindly devoted their time to the study.

Author information

Author notes

  1. These authors contributed equally: Yue Dong, Yanhong Gong.

Authors and Affiliations

  1. School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China

    Yue Dong, Yanhong Gong, Rongrong An, Na Sun, Zhenyuan Chen & Xiaoxv Yin

  2. Department of Community Health Management, Baoan Central Hospital of Shenzhen, Shenzhen, 518000, PR China

    Yanping Han, Hanbing Yu, Xiaozhou Zeng & Zimei Chen

Authors
  1. Yue Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanhong Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yanping Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanbing Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaozhou Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zimei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rongrong An
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Na Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhenyuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiaoxv Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors were involved in study conception and design. XY, YD and YG created the concept and design of the manuscript. YD, YH, HY and ZC conducted the data analysis and drafted the manuscript. XZ, RA and ZC contributed to the interpretation of results and revised the manuscript. NS contributed to the acquisition of data. XY is the guarantor of this article.

Corresponding author

Correspondence to Xiaoxv Yin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, Y., Gong, Y., Han, Y. et al. Body weight, weight change and the risk of cardiovascular disease in patients with hypertension: a primary-care cohort study. Int J Obes 47, 848–854 (2023). https://doi.org/10.1038/s41366-023-01335-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-023-01335-z

Search

Advanced search

Quick links